Last day of trading in subscribed paid shares ("BTA") in Acarix AB ("Acarix" or the “Company") will
be Thursday the 1 October 2020 and stop day will be Monday the 5 October 2020.
In the rights issue, which was completed on 8 September 2020, the Company issued 86,156,738 shares.
Through the rights issue, Acarix raises approx. SEK 56 million before deduction of costs related to the
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.